Fig. 1 · Structure
Documents & Downloads
Insulin lispro
Insulin Analogue
Insulin lispro is a rapid-acting insulin analogue that targets the insulin receptor to effectively lower blood glucose levels. This recombinant human insulin is primarily used in research focused on hyperglycemia associated with diabetes mellitus. Its rapid onset of action makes it an essential tool for studying glycemic control and insulin response in various experimental settings.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 133107-64-9 |
| Applications | Insulin Analogue |
| Formula | C257H383N65O77S6 |
| Molecular Weight | 5807.63 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.